作者
Alina Kurolap, Orly Eshach-Adiv, Tova Hershkovitz, Tamar Paperna, Adi Mory, Danit Oz-Levi, Yaniv Zohar, Hanna Mandel, Judith Chezar, David Azoulay, Sarit Peleg, Elizabeth E Half, Vered Yahalom, Lilach Finkel, Omer Weissbrod, Dan Geiger, Adi Tabib, Ron Shaoul, Daniella Magen, Lilach Bonstein, Dror Mevorach, Hagit N Baris
发表日期
2017/7/6
期刊
New England Journal of Medicine
卷号
377
期号
1
页码范围
87-89
出版商
Massachusetts Medical Society
简介
CD55 (complement decay-accelerating factor) inhibits the alternative and classical arms of the complement pathway. Three patients with protein-losing enteropathy and a genetic variant predicted to result in loss of function of CD55 had a response to eculizumab.
学术搜索中的文章
A Kurolap, O Eshach-Adiv, T Hershkovitz, T Paperna… - New England Journal of Medicine, 2017